Skip to main content

BARCLAYS PLC

Position in ARCT — Arcturus Therapeutics Holdings Inc.

CIK 312069 LONDON, X0

Position in ARCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$92,567
-$12,655 QoQ
Shares Held
13,775
+1.1% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 133 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARCT Over Time

Shares Held

Position Value (USD)

Derivatives in ARCT

reported options exposure · as of Sep 30, 2025
CallValue
$1,262,455
CallShares
68,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. ARCT ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ARCT

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,567 13,775
2026-03-31 $105,222 13,630
2025-12-31 $310,110 50,589
2025-09-30 $1,262,455 68,500
2025-09-30 $1,510,374 81,952
2025-06-30 $1,233,256 94,793
2025-03-31 $503,310 47,527
2024-12-31 $1,019,591 60,082
2024-09-30 $1,564,701 67,415
2024-09-30 $1,044,450 45,000
2024-09-30 $1,044,450 45,000
2024-06-30 $3,652,500 150,000
2024-06-30 $1,059,249 43,501
2024-03-31 $1,207,074 35,744
2023-12-31 $2,664,568 84,509
2023-09-30 $2,873,531 112,467
2023-06-30 $2,792,140 97,355
2023-03-31 $2,071,798 86,433
2022-12-31 $1,840,091 108,496
2022-09-30 $1,789,411 120,743
2022-06-30 $702,586 44,637
2022-03-31 $96,515 3,580
2021-12-31 $948,307 25,623
2021-09-30 $544,548 11,397
2021-06-30 $116,308 3,437
2021-03-31 $1,409,609 34,131
2020-12-31 $3,288,464 75,806
2020-09-30 $371,684 8,664
2020-06-30 $1,478,760 31,638
2020-03-31 $36,339 2,674